These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2860597)
1. The analgesic activity of D-Arg2-dermorphin and its N-terminal tetrapeptide analogs after subcutaneous administration in mice. Sasaki Y; Matsui M; Fujita H; Hosono M; Taguchi M; Suzuki K; Sakurada S; Sato T; Sakurada T; Kisara K Neuropeptides; 1985 Feb; 5(4-6):391-4. PubMed ID: 2860597 [TBL] [Abstract][Full Text] [Related]
2. D-Arg2-dermorphin tetrapeptide analogs: a potent and long-lasting analgesic activity after subcutaneous administration. Sasaki Y; Matsui M; Taguchi M; Suzuki K; Sakurada S; Sato T; Sakurada T; Kisara K Biochem Biophys Res Commun; 1984 Apr; 120(1):214-8. PubMed ID: 6712689 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the antinociceptive effects of new [D-Arg2]-dermorphin tetrapeptide analogs and morphine in mice. Chaki K; Sakurada S; Sakurada T; Sato T; Kawamura S; Kisara K; Watanabe H; Suzuki K Pharmacol Biochem Behav; 1988 Oct; 31(2):439-44. PubMed ID: 2907624 [TBL] [Abstract][Full Text] [Related]
4. N-terminal tetrapeptide of dermorphin and D-Arg-substituted tetrapeptides: inactivation process of the antinociceptive activity by peptidase. Chaki K; Sakurada S; Sakurada T; Kisara K; Suzuki K Life Sci; 1990; 46(23):1671-8. PubMed ID: 1972532 [TBL] [Abstract][Full Text] [Related]
6. On the degradation of dermorphin and D-Arg2-dermorphin analogs by a soluble rat brain extract. Sasaki Y; Hosono M; Matsui M; Fujita H; Suzuki K; Sakurada S; Sakurada T; Kisara K Biochem Biophys Res Commun; 1985 Aug; 130(3):964-70. PubMed ID: 2862871 [TBL] [Abstract][Full Text] [Related]
7. Physical dependence of a dermorphin tetrapeptide analog, [D-Arg2, Sar4]-dermorphin (1-4) in the rat. Nakata N; Sakurada S; Sakurada T; Kisara K; Sasaki Y; Suzuki K Pharmacol Biochem Behav; 1986 Jan; 24(1):27-31. PubMed ID: 3945663 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of an orally available and long-acting analgesic peptide, N(alpha)-amidino-Tyr-D-Arg-Phe-MebetaAla-OH (ADAMB). Ogawa T; Miyamae T; Murayama K; Okuyama K; Okayama T; Hagiwara M; Sakurada S; Morikawa T J Med Chem; 2002 Nov; 45(23):5081-9. PubMed ID: 12408719 [TBL] [Abstract][Full Text] [Related]
12. A new class opioid peptide, [D-Arg2, beta-Ala4]-dermorphin tetrapeptide; physical dependence liability in mice. Chaki K; Sakurada S; Sakurada T; Sato T; Kawamura S; Kisara K; Sasaki Y; Suzuki K Neuropeptides; 1989; 13(2):83-8. PubMed ID: 2567974 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues. Marastoni M; Salvadori S; Balboni G; Borea PA; Marzola G; Tomatis R J Med Chem; 1987 Sep; 30(9):1538-42. PubMed ID: 2887656 [TBL] [Abstract][Full Text] [Related]
14. Studies on analgesic oligopeptides. III. Synthesis and analgesic activity after subcutaneous administration of [D-Arg2]dermorphin and its N-terminal tetrapeptide analogs. Sasaki Y; Matsui M; Fujita H; Hosono M; Taguchi M; Suzuki K; Sakurada S; Sato T; Sakurada T; Kisara K Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1528-36. PubMed ID: 4042230 [No Abstract] [Full Text] [Related]
15. Antinociception and physical dependence produced by [D-Arg2] dermorphin tetrapeptide analogues and morphine in rats. Chaki K; Kawamura S; Kisara K; Sakurada S; Sakurada T; Sasaki Y; Sato T; Susuki K Br J Pharmacol; 1988 Sep; 95(1):15-22. PubMed ID: 2905901 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological activity of the N-terminal dermorphin tetrapeptide analogs with CH2-NH peptide bond isosteres. Salvadori S; Guerrini R; Borea PA; Tomatis R Int J Pept Protein Res; 1992 Nov; 40(5):437-44. PubMed ID: 1362392 [TBL] [Abstract][Full Text] [Related]
17. Comparison of opioid activity between a N-terminal tetrapeptide analogue of dermorphin, H-Tyr-D-Arg-Phe-beta-Ala-OH and morphine. Sato T; Takahashi N; Tan-No K; Kisara K; Sakurada T; Sakurada S Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):581-6. PubMed ID: 9819802 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of carboxyl terminally extended dermorphins. Marastoni M; Salvadori S; Balboni G; Marzola G; degli Uberti EC; Tomatis R Int J Pept Protein Res; 1986 Sep; 28(3):274-81. PubMed ID: 3781741 [TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier permeability of novel [D-arg2]dermorphin (1-4) analogs: transport property is related to the slow onset of antinociceptive activity in the central nervous system. Deguchi Y; Naito Y; Ohtsuki S; Miyakawa Y; Morimoto K; Hosoya K; Sakurada S; Terasaki T J Pharmacol Exp Ther; 2004 Jul; 310(1):177-84. PubMed ID: 15031301 [TBL] [Abstract][Full Text] [Related]
20. Comparison of opioid properties between D-Arg-containing dipeptides and tetrapeptides. Sato T; Sakurada S; Sakurada T; Kisara K; Suzuki K Biochem Pharmacol; 1992 Feb; 43(4):717-23. PubMed ID: 1347216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]